A Phase 1b Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Drug-Drug Interaction of PLX5622 in Patients With Rheumatoid Arthritis Who Are Receiving Methotrexate.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2012
At a glance
- Drugs Methotrexate; PLX 5622
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 10 Apr 2012 Actual patients number is 26 as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.